Displaying publications 1 - 20 of 313 in total

Abstract:
Sort:
  1. Mohamad Zamani NS, Wan Zaki WMD, Abd Hamid Z, Baseri Huddin A
    PeerJ, 2022;10:e14513.
    PMID: 36573241 DOI: 10.7717/peerj.14513
    BACKGROUND AND AIMS: A microscopic image has been used in cell analysis for cell type identification and classification, cell counting and cell size measurement. Most previous research works are tedious, including detailed understanding and time-consuming. The scientists and researchers are seeking modern and automatic cell analysis approaches in line with the current in-demand technology.

    OBJECTIVES: This article provides a brief overview of a general cell and specific stem cell analysis approaches from the history of cell discovery up to the state-of-the-art approaches.

    METHODOLOGY: A content description of the literature study has been surveyed from specific manuscript databases using three review methods: manuscript identification, screening, and inclusion. This review methodology is based on Prism guidelines in searching for originality and novelty in studies concerning cell analysis.

    RESULTS: By analysing generic cell and specific stem cell analysis approaches, current technology offers tremendous potential in assisting medical experts in performing cell analysis using a method that is less laborious, cost-effective, and reduces error rates.

    CONCLUSION: This review uncovers potential research gaps concerning generic cell and specific stem cell analysis. Thus, it could be a reference for developing automated cells analysis approaches using current technology such as artificial intelligence and deep learning.

    Matched MeSH terms: Artificial Intelligence*
  2. Hoang YN, Chen YL, Ho DKN, Chiu WC, Cheah KJ, Mayasari NR, et al.
    JAMA Netw Open, 2023 Dec 01;6(12):e2350367.
    PMID: 38150258 DOI: 10.1001/jamanetworkopen.2023.50367
    Matched MeSH terms: Artificial Intelligence*
  3. Yang XS, Chien SF, Ting TO
    ScientificWorldJournal, 2014;2014:425853.
    PMID: 25610904 DOI: 10.1155/2014/425853
    Matched MeSH terms: Artificial Intelligence*
  4. Kalatehjari R, Rashid AS, Ali N, Hajihassani M
    ScientificWorldJournal, 2014;2014:973093.
    PMID: 24991652 DOI: 10.1155/2014/973093
    Over the last few years, particle swarm optimization (PSO) has been extensively applied in various geotechnical engineering including slope stability analysis. However, this contribution was limited to two-dimensional (2D) slope stability analysis. This paper applied PSO in three-dimensional (3D) slope stability problem to determine the critical slip surface (CSS) of soil slopes. A detailed description of adopted PSO was presented to provide a good basis for more contribution of this technique to the field of 3D slope stability problems. A general rotating ellipsoid shape was introduced as the specific particle for 3D slope stability analysis. A detailed sensitivity analysis was designed and performed to find the optimum values of parameters of PSO. Example problems were used to evaluate the applicability of PSO in determining the CSS of 3D slopes. The first example presented a comparison between the results of PSO and PLAXI-3D finite element software and the second example compared the ability of PSO to determine the CSS of 3D slopes with other optimization methods from the literature. The results demonstrated the efficiency and effectiveness of PSO in determining the CSS of 3D soil slopes.
    Matched MeSH terms: Artificial Intelligence*
  5. Sharma V, Singh A, Chauhan S, Sharma PK, Chaudhary S, Sharma A, et al.
    Curr Drug Deliv, 2024;21(6):870-886.
    PMID: 37670704 DOI: 10.2174/1567201821666230905090621
    Drug discovery and development (DDD) is a highly complex process that necessitates precise monitoring and extensive data analysis at each stage. Furthermore, the DDD process is both timeconsuming and costly. To tackle these concerns, artificial intelligence (AI) technology can be used, which facilitates rapid and precise analysis of extensive datasets within a limited timeframe. The pathophysiology of cancer disease is complicated and requires extensive research for novel drug discovery and development. The first stage in the process of drug discovery and development involves identifying targets. Cell structure and molecular functioning are complex due to the vast number of molecules that function constantly, performing various roles. Furthermore, scientists are continually discovering novel cellular mechanisms and molecules, expanding the range of potential targets. Accurately identifying the correct target is a crucial step in the preparation of a treatment strategy. Various forms of AI, such as machine learning, neural-based learning, deep learning, and network-based learning, are currently being utilised in applications, online services, and databases. These technologies facilitate the identification and validation of targets, ultimately contributing to the success of projects. This review focuses on the different types and subcategories of AI databases utilised in the field of drug discovery and target identification for cancer.
    Matched MeSH terms: Artificial Intelligence*
  6. Tsigaris P, Kendall G, Teixeira da Silva JA
    J Prof Nurs, 2023;49:188-189.
    PMID: 38042556 DOI: 10.1016/j.profnurs.2023.08.002
    The debate surrounding "predatory publishing" continues to be unable to find entirely effective solutions to dealing with this problem, despite fervent efforts by many academics and policy makers around the world. Given this situation, we were interested in appreciating whether ChatGPT would be able to offer insight and solutions, to complement current human-based efforts.
    Matched MeSH terms: Artificial Intelligence*
  7. Tan GC, Wong YP
    Malays J Pathol, 2024 Aug;46(2):231-232.
    PMID: 39207000
    No abstract available.
    Matched MeSH terms: Artificial Intelligence*
  8. Wah JNK
    J Robot Surg, 2025 Jan 07;19(1):47.
    PMID: 39776281 DOI: 10.1007/s11701-024-02205-0
    Artificial intelligence and robotics are revolutionizing surgical practices by enhancing precision, efficiency, and patient outcomes. With global healthcare systems increasingly adopting AI-driven technologies, the integration of robotics in surgery addresses critical challenges such as surgical accuracy, minimally invasive techniques, and healthcare accessibility. However, disparities in access and ethical concerns regarding automation persist globally, necessitating a balanced discourse on these advancements. The primary objective of the review is to explore the intersection of AI and robotic technologies in surgical practices, highlighting key innovations, their impact on precision medicine, and future trajectories. The novelty of the review lies in synthesizing findings across diverse surgical specialties, including urology, plastic surgery, ophthalmology, and pediatric surgery, to provide a comprehensive understanding of AI's transformative role. The systematic review evaluates the integration of AI and robotics in surgery, synthesizing studies published in 2024. It follows PRISMA guidelines for study selection, data extraction, and synthesis. The review assesses surgical specialties, AI technologies, and outcomes like accuracy, recovery, and complications, ensuring methodological rigor and transparency. The findings indicate substantial advancements in AI-driven surgical systems, improving decision-making, reducing surgical errors, and facilitating personalized treatment strategies. Notable breakthroughs include AI-enhanced imaging, real-time data analysis, and automated robotic instruments, which collectively improve procedural efficiency and patient safety. The discussion emphasizes the critical implications of these innovations, particularly in advancing minimally invasive techniques and expanding surgical capabilities in complex procedures. However, challenges such as cost, ethical considerations, and the need for rigorous training protocols are highlighted as barriers to widespread adoption. The review underscores the implications for policymakers, healthcare institutions, and technology developers to address these barriers and promote equitable access to AI-driven surgical solutions. Limitations include the reliance on recent studies, necessitating long-term evaluations of clinical outcomes. Future research should focus on integrating AI with emerging technologies like augmented reality, fostering interdisciplinary collaboration, and addressing socio-ethical dimensions to fully realize the potential of AI in surgical advancements.
    Matched MeSH terms: Artificial Intelligence*
  9. Anisha SA, Sen A, Bain C
    J Med Internet Res, 2024 Jul 16;26:e56114.
    PMID: 39012688 DOI: 10.2196/56114
    BACKGROUND: The rising prevalence of noncommunicable diseases (NCDs) worldwide and the high recent mortality rates (74.4%) associated with them, especially in low- and middle-income countries, is causing a substantial global burden of disease, necessitating innovative and sustainable long-term care solutions.

    OBJECTIVE: This scoping review aims to investigate the impact of artificial intelligence (AI)-based conversational agents (CAs)-including chatbots, voicebots, and anthropomorphic digital avatars-as human-like health caregivers in the remote management of NCDs as well as identify critical areas for future research and provide insights into how these technologies might be used effectively in health care to personalize NCD management strategies.

    METHODS: A broad literature search was conducted in July 2023 in 6 electronic databases-Ovid MEDLINE, Embase, PsycINFO, PubMed, CINAHL, and Web of Science-using the search terms "conversational agents," "artificial intelligence," and "noncommunicable diseases," including their associated synonyms. We also manually searched gray literature using sources such as ProQuest Central, ResearchGate, ACM Digital Library, and Google Scholar. We included empirical studies published in English from January 2010 to July 2023 focusing solely on health care-oriented applications of CAs used for remote management of NCDs. The narrative synthesis approach was used to collate and summarize the relevant information extracted from the included studies.

    RESULTS: The literature search yielded a total of 43 studies that matched the inclusion criteria. Our review unveiled four significant findings: (1) higher user acceptance and compliance with anthropomorphic and avatar-based CAs for remote care; (2) an existing gap in the development of personalized, empathetic, and contextually aware CAs for effective emotional and social interaction with users, along with limited consideration of ethical concerns such as data privacy and patient safety; (3) inadequate evidence of the efficacy of CAs in NCD self-management despite a moderate to high level of optimism among health care professionals regarding CAs' potential in remote health care; and (4) CAs primarily being used for supporting nonpharmacological interventions such as behavioral or lifestyle modifications and patient education for the self-management of NCDs.

    CONCLUSIONS: This review makes a unique contribution to the field by not only providing a quantifiable impact analysis but also identifying the areas requiring imminent scholarly attention for the ethical, empathetic, and efficacious implementation of AI in NCD care. This serves as an academic cornerstone for future research in AI-assisted health care for NCD management.

    TRIAL REGISTRATION: Open Science Framework; https://doi.org/10.17605/OSF.IO/GU5PX.

    Matched MeSH terms: Artificial Intelligence*
  10. Ali M
    Clin Teach, 2025 Apr;22(2):e70040.
    PMID: 39956546 DOI: 10.1111/tct.70040
    Artificial intelligence (AI) is redefining medical education, bringing new dimensions of personalized learning, enhanced visualization and simulation-based clinical training to the forefront. Additionally, AI-powered simulations offer realistic, immersive training opportunities, preparing students for complex clinical situations and fostering interprofessional collaboration skills essential for modern healthcare. However, the integration of AI into medical education presents challenges, particularly around ethical considerations, skill atrophy due to overreliance and the exacerbation of the digital divide among educational institutions. Addressing these challenges demands a balanced approach that includes blended learning models, digital literacy and faculty development to ensure AI serves as a supplement to, rather than a replacement for, core medical competencies. As medical education evolves alongside AI, institutions must prioritize strategies that preserve human-centred skills while advancing technological innovation to prepare future healthcare professionals for an AI-enhanced landscape.
    Matched MeSH terms: Artificial Intelligence*
  11. Gangwal A, Ansari A, Ahmad I, Azad AK, Wan Sulaiman WMA
    Comput Biol Med, 2024 Sep;179:108734.
    PMID: 38964243 DOI: 10.1016/j.compbiomed.2024.108734
    Artificial intelligence (AI) has played a vital role in computer-aided drug design (CADD). This development has been further accelerated with the increasing use of machine learning (ML), mainly deep learning (DL), and computing hardware and software advancements. As a result, initial doubts about the application of AI in drug discovery have been dispelled, leading to significant benefits in medicinal chemistry. At the same time, it is crucial to recognize that AI is still in its infancy and faces a few limitations that need to be addressed to harness its full potential in drug discovery. Some notable limitations are insufficient, unlabeled, and non-uniform data, the resemblance of some AI-generated molecules with existing molecules, unavailability of inadequate benchmarks, intellectual property rights (IPRs) related hurdles in data sharing, poor understanding of biology, focus on proxy data and ligands, lack of holistic methods to represent input (molecular structures) to prevent pre-processing of input molecules (feature engineering), etc. The major component in AI infrastructure is input data, as most of the successes of AI-driven efforts to improve drug discovery depend on the quality and quantity of data, used to train and test AI algorithms, besides a few other factors. Additionally, data-gulping DL approaches, without sufficient data, may collapse to live up to their promise. Current literature suggests a few methods, to certain extent, effectively handle low data for better output from the AI models in the context of drug discovery. These are transferring learning (TL), active learning (AL), single or one-shot learning (OSL), multi-task learning (MTL), data augmentation (DA), data synthesis (DS), etc. One different method, which enables sharing of proprietary data on a common platform (without compromising data privacy) to train ML model, is federated learning (FL). In this review, we compare and discuss these methods, their recent applications, and limitations while modeling small molecule data to get the improved output of AI methods in drug discovery. Article also sums up some other novel methods to handle inadequate data.
    Matched MeSH terms: Artificial Intelligence*
  12. Olayiwola Babarinsa, Hailiza Kamarulhaili
    MATEMATIKA, 2019;35(1):25-38.
    MyJurnal
    The proposed modified methods of Cramer's rule consider the column vector as well as the coefficient matrix concurrently in the linear system. The modified methods can be applied since Cramer's rule is typically known for solving the linear systems in $WZ$ factorization to yield Z-matrix. Then, we presented our results to show that there is no tangible difference in performance time between Cramer's rule and the modified methods in the factorization from improved versions of MATLAB. Additionally, the Frobenius norm of the modified methods in the factorization is better than using Cramer's rule irrespective of the version of MATLAB used.
    Matched MeSH terms: Artificial Intelligence
  13. Nurhafizah Jamain, Ismail Musirin, Mohd Helmi Mansor, Muhammad Murtadha Othman, Siti Aliyah Mohd Salleh
    MyJurnal
    This paper presents adaptive particle swarm optimization for solving non-convex economic dispatch problems. In this study, a new technique was developed known as adaptive particle swarm optimization (APSO), to alleviate the problems experienced in the traditional particle swarm optimisation (PSO). The traditional PSO was reported that this technique always stuck at local minima. In APSO, economic dispatch problem are considered with valve point effects. The search efficiency was improved when a new parameter was inserted into the velocity term. This has achieved local minima. In order to show the effectiveness of the proposed technique, this study examined two case studies, with and without contingency.
    Matched MeSH terms: Artificial Intelligence
  14. Asteris PG, Gandomi AH, Armaghani DJ, Tsoukalas MZ, Gavriilaki E, Gerber G, et al.
    J Cell Mol Med, 2024 Feb;28(4):e18105.
    PMID: 38339761 DOI: 10.1111/jcmm.18105
    Complement inhibition has shown promise in various disorders, including COVID-19. A prediction tool including complement genetic variants is vital. This study aims to identify crucial complement-related variants and determine an optimal pattern for accurate disease outcome prediction. Genetic data from 204 COVID-19 patients hospitalized between April 2020 and April 2021 at three referral centres were analysed using an artificial intelligence-based algorithm to predict disease outcome (ICU vs. non-ICU admission). A recently introduced alpha-index identified the 30 most predictive genetic variants. DERGA algorithm, which employs multiple classification algorithms, determined the optimal pattern of these key variants, resulting in 97% accuracy for predicting disease outcome. Individual variations ranged from 40 to 161 variants per patient, with 977 total variants detected. This study demonstrates the utility of alpha-index in ranking a substantial number of genetic variants. This approach enables the implementation of well-established classification algorithms that effectively determine the relevance of genetic variants in predicting outcomes with high accuracy.
    Matched MeSH terms: Artificial Intelligence
  15. Jawahar N, Ponnambalam SG, Sivakumar K, Thangadurai V
    ScientificWorldJournal, 2014;2014:458959.
    PMID: 24790568 DOI: 10.1155/2014/458959
    Products such as cars, trucks, and heavy machinery are assembled by two-sided assembly line. Assembly line balancing has significant impacts on the performance and productivity of flow line manufacturing systems and is an active research area for several decades. This paper addresses the line balancing problem of a two-sided assembly line in which the tasks are to be assigned at L side or R side or any one side (addressed as E). Two objectives, minimum number of workstations and minimum unbalance time among workstations, have been considered for balancing the assembly line. There are two approaches to solve multiobjective optimization problem: first approach combines all the objectives into a single composite function or moves all but one objective to the constraint set; second approach determines the Pareto optimal solution set. This paper proposes two heuristics to evolve optimal Pareto front for the TALBP under consideration: Enumerative Heuristic Algorithm (EHA) to handle problems of small and medium size and Simulated Annealing Algorithm (SAA) for large-sized problems. The proposed approaches are illustrated with example problems and their performances are compared with a set of test problems.
    Matched MeSH terms: Artificial Intelligence*
  16. Yigitcanlar T, Butler L, Windle E, Desouza KC, Mehmood R, Corchado JM
    Sensors (Basel), 2020 May 25;20(10).
    PMID: 32466175 DOI: 10.3390/s20102988
    In recent years, artificial intelligence (AI) has started to manifest itself at an unprecedented pace. With highly sophisticated capabilities, AI has the potential to dramatically change our cities and societies. Despite its growing importance, the urban and social implications of AI are still an understudied area. In order to contribute to the ongoing efforts to address this research gap, this paper introduces the notion of an artificially intelligent city as the potential successor of the popular smart city brand-where the smartness of a city has come to be strongly associated with the use of viable technological solutions, including AI. The study explores whether building artificially intelligent cities can safeguard humanity from natural disasters, pandemics, and other catastrophes. All of the statements in this viewpoint are based on a thorough review of the current status of AI literature, research, developments, trends, and applications. This paper generates insights and identifies prospective research questions by charting the evolution of AI and the potential impacts of the systematic adoption of AI in cities and societies. The generated insights inform urban policymakers, managers, and planners on how to ensure the correct uptake of AI in our cities, and the identified critical questions offer scholars directions for prospective research and development.
    Matched MeSH terms: Artificial Intelligence*
  17. Kubicek J, Penhaker M, Krejcar O, Selamat A
    Sensors (Basel), 2021 Jan 27;21(3).
    PMID: 33513910 DOI: 10.3390/s21030847
    There are various modern systems for the measurement and consequent acquisition of valuable patient's records in the form of medical signals and images, which are supposed to be processed to provide significant information about the state of biological tissues [...].
    Matched MeSH terms: Artificial Intelligence*
  18. Mak KK, Pichika MR
    Drug Discov Today, 2019 03;24(3):773-780.
    PMID: 30472429 DOI: 10.1016/j.drudis.2018.11.014
    Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process. At present, the pharmaceutical industry is facing challenges in sustaining their drug development programmes because of increased R&D costs and reduced efficiency. In this review, we discuss the major causes of attrition rates in new drug approvals, the possible ways that AI can improve the efficiency of the drug development process and collaboration of pharmaceutical industry giants with AI-powered drug discovery firms.
    Matched MeSH terms: Artificial Intelligence*
  19. Dikshit A, Pradhan B
    Sci Total Environ, 2021 Dec 20;801:149797.
    PMID: 34467917 DOI: 10.1016/j.scitotenv.2021.149797
    Accurate prediction of any type of natural hazard is a challenging task. Of all the various hazards, drought prediction is challenging as it lacks a universal definition and is getting adverse with climate change impacting drought events both spatially and temporally. The problem becomes more complex as drought occurrence is dependent on a multitude of factors ranging from hydro-meteorological to climatic variables. A paradigm shift happened in this field when it was found that the inclusion of climatic variables in the data-driven prediction model improves the accuracy. However, this understanding has been primarily using statistical metrics used to measure the model accuracy. The present work tries to explore this finding using an explainable artificial intelligence (XAI) model. The explainable deep learning model development and comparative analysis were performed using known understandings drawn from physical-based models. The work also tries to explore how the model achieves specific results at different spatio-temporal intervals, enabling us to understand the local interactions among the predictors for different drought conditions and drought periods. The drought index used in the study is Standard Precipitation Index (SPI) at 12 month scales applied for five different regions in New South Wales, Australia, with the explainable algorithm being SHapley Additive exPlanations (SHAP). The conclusions drawn from SHAP plots depict the importance of climatic variables at a monthly scale and varying ranges of annual scale. We observe that the results obtained from SHAP align with the physical model interpretations, thus suggesting the need to add climatic variables as predictors in the prediction model.
    Matched MeSH terms: Artificial Intelligence*
  20. Tahir GA, Loo CK
    Comput Biol Med, 2021 12;139:104972.
    PMID: 34749093 DOI: 10.1016/j.compbiomed.2021.104972
    Food recognition systems recently garnered much research attention in the relevant field due to their ability to obtain objective measurements for dietary intake. This feature contributes to the management of various chronic conditions. Challenges such as inter and intraclass variations alongside the practical applications of smart glasses, wearable cameras, and mobile devices require resource-efficient food recognition models with high classification performance. Furthermore, explainable AI is also crucial in health-related domains as it characterizes model performance, enhancing its transparency and objectivity. Our proposed architecture attempts to address these challenges by drawing on the strengths of the transfer learning technique upon initializing MobiletNetV3 with weights from a pre-trained model of ImageNet. The MobileNetV3 achieves superior performance using the squeeze and excitation strategy, providing unequal weight to different input channels and contrasting equal weights in other variants. Despite being fast and efficient, there is a high possibility for it to be stuck in the local optima like other deep neural networks, reducing the desired classification performance of the model. Thus, we overcome this issue by applying the snapshot ensemble approach as it enables the M model in a single training process without any increase in the required training time. As a result, each snapshot in the ensemble visits different local minima before converging to the final solution which enhances recognition performance. On overcoming the challenge of explainability, we argue that explanations cannot be monolithic, since each stakeholder perceive the results', explanations based on different objectives and aims. Thus, we proposed a user-centered explainable artificial intelligence (AI) framework to increase the trust of the involved parties by inferencing and rationalizing the results according to needs and user profile. Our framework is comprehensive in terms of a dietary assessment app as it detects Food/Non-Food, food categories, and ingredients. Experimental results on the standard food benchmarks and newly contributed Malaysian food dataset for ingredient detection demonstrated superior performance on an integrated set of measures over other methodologies.
    Matched MeSH terms: Artificial Intelligence*
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links